Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2013007784
pages 435-448

Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer

Suzy V. Torti
Departments of Molecular, Microbial & Structural Biology; UCONN Health Center, Farmington, CT
Frank M. Torti
Internal Medicine, University of Connecticut Health Center, Farmington, CT

RESUMO

Despite many recent advances, breast cancer remains a clinical challenge. Current issues include improving prognostic evaluation and increasing therapeutic options for women whose tumors are refractory to current frontline therapies. Iron metabolism is frequently disrupted in breast cancer, and may offer an opportunity to address these challenges. Iron enhances breast tumor initiation, growth and metastases. Iron may contribute to breast tumor initiation by promoting redox cycling of estrogen metabolites. Up-regulation of iron import and down-regulation of iron export may enable breast cancer cells to acquire and retain excess iron. Alterations in iron metabolism in macrophages and other cells of the tumor microenvironment may also foster breast tumor growth. Expression of iron metabolic genes in breast tumors is predictive of breast cancer prognosis. Iron chelators and other strategies designed to limit iron may have therapeutic value in breast cancer. The dependence of breast cancer on iron presents rich opportunities for improved prognostic evaluation and therapeutic intervention.

Palavras-chave: iron, breast cancer, estrogen

Articles with similar content:

Copine 3 as a Novel Potential Drug Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Kunnathur Murugesan Sakthivel , Venugopal Vinod Prabhu
Regulation of Estrogen Receptor α Function in Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 1
Nancy E. Davidson, Anne T. Ferguson
An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Reuben H. Kim, Ki-Hyuk Shin
Role of the Progesterone Receptor (PR) and the PR Isoforms in Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.13, 2007, issue 4
Orla Mc Cormack, Michael J. Kerin, Amanda McCann, Michele Harrison
Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 5-6
Elaine M. Walsh, Maccon M. Keane, David A. Wink, Grace Callagy, Sharon A. Glynn